Tumor suppression effect of Solanum nigrum polysaccharide fraction on Breast cancer via immunomodulation

International Journal of Biological Macromolecules

Volumn 92, Issue , 2016, Pages 185-193

  Razali, Faizan Naeem ^a   Sinniah, Saravana Kumar ^a   Hussin, Huzlinda ^b   Zainal Abidin, Nurhayati ^a   Shuib, Adawiyah Suriza ^a,c  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^c UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Immunomodulation; Plant polysaccharide; Solanum nigrum

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; GAMMA INTERFERON; INTERLEUKIN 4; INTERLEUKIN 6; POLYSACCHARIDE; SOLANUM NIGRUM POLYSACCHARIDE; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; CYTOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER INHIBITION; CONTROLLED STUDY; DRUG CYTOTOXICITY; FEMALE; IMMUNOMODULATION; MACROPHAGE; MOUSE; NATURAL KILLER CELL; NONHUMAN; SOLANUM NIGRUM; T LYMPHOCYTE; TUMOR REGRESSION; ANIMAL; BAGG ALBINO MOUSE; BODY WEIGHT; CELL DEATH; CELL PROLIFERATION; CHEMISTRY; DISEASE COURSE; DRUG EFFECTS; FLUORESCENT ANTIBODY TECHNIQUE; FRACTIONATION; IMMUNOLOGY; INFRARED SPECTROSCOPY; MAMMARY NEOPLASMS, EXPERIMENTAL; METABOLISM; PATHOLOGY; STAINING; TUMOR CELL LINE; TUNEL ASSAY;

ANIMALS; BODY WEIGHT; CELL DEATH; CELL LINE, TUMOR; CELL PROLIFERATION; CHEMICAL FRACTIONATION; CYTOKINES; DISEASE PROGRESSION; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOMODULATION; IN SITU NICK-END LABELING; KILLER CELLS, NATURAL; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE, INBRED BALB C; POLYSACCHARIDES; SOLANUM NIGRUM; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; STAINING AND LABELING;

EID: 84989864862     PISSN: 01418130     EISSN: 18790003     Source Type: Journal    
DOI: 10.1016/j.ijbiomac.2016.06.079     Document Type: Article

References (59)

1. [1] Seigel, R.L., Miller, K.D., Jemal, A., Cancer statistics, 2015. CA: Cancer J. Clin. 65:1 (2015), 5–29.
2. [2] Palumbo, M.O., Kavan, P., Miller, W.H. Jr., Panasci, L., Assouline, S., Johnson, N., Cohen, V., Patenaude, F., Pollak, M., Jagoe, R.T., Batist, G., Systemic cancer therapy: achievements and challenges that lie ahead. Front. Pharmacol., 4, 2013.
3. [3] Antonarakis, E.S., Drake, C.G., Current status of immunological therapies for prostate cancer. Curr. Opin. Urol. 20:3 (2010), 241–246.
4. [4] Devasagayam, T.P.A., Sainis, K.B., Immune system and antioxidants, especially those derived from Indian medicinal plants. Indian J. Exp. Biol. 40:6 (2000), 639–655.
5. [5] Ramberg, J.E., Nelson, E.D., Sinnott, R.A., Immunomodulatory dietary polysaccharides: a systematic review of the literature. Nutr. J. 9:54 (2010), 1–22.
6. [6] Ernst, B., Magnani, J.L., From carbohydrate leads to glycomimetic drugs. Nat. Rev. Drug Discov. 8:8 (2009), 661–677.
7. [7] Schepetkin, I.A., Quinn, M.T., Botanical polysaccharides: macrophage immunomodulation and therapeutic potential. Int. Immunopharmacol. 6:3 (2006), 317–333.
8. [8] Edmonds, Jennifer, M., James Chweya, A., Black nightshades. Solanum nigrum L. and related species. Promoting the conservation and use of underutilized and neglected crops. 15, 1997, Institute of Plant Genetics and Crop Plant Research, Gatersleben/International Plant Genetic Resources Institute, Rome, Italy (assessed 11.07.16) http://pdf.usaid.gov/pdf_docs/Pnach882.pdf.
9. [9] Jain, R., Sharma, A., Gupta, S., Sarethy, I.P., Gabrani, R., Solanum nigrum: current perspectives on therapeutic properties. Altern. Med. Rev. 16:1 (2011), 78–85.
10. [10] Akhtar, M.S., Munir, M., Evaluation of the gastric antiulcerogenic effects of Solanum nigrum, Brassica oleracea and Ocimum basilicum in rats. J. Ethnopharmacol. 27:1 (1989), 163–176.
11. [11] Sultana, S., Perwaiz, S., Iqbal, M., Athar, M., Crude extracts of hepatoprotective plants, Solanum nigrum and Cichorium intybus inhibit free radical-mediated DNA damage. J. Ethnopharmacol. 45:3 (1995), 189–192.
12. [12] Hu, K., Kobayashi, H., Dong, A., Jing, Y., Iwasaki, S., Yao, X., Antineoplastic agents III: steroidal glycosides from solanum nigrum. Planta Med. 65:1 (1999), 035–038.
13. [13] Heo, K.S., Lee, S.J., Ko, J.H., Lim, K., Lim, K.T., Glycoprotein isolated from Solanum nigrum L. inhibits the DNA-binding activities of NF-κB and AP-1, and increases the production of nitric oxide in TPA-stimulated MCF-7 cells. Toxicol. In Vitro 18:6 (2004), 755–763.
14. [14] Li, J., Li, Q., Peng, Y., Zhao, R., Han, Z., Gao, D., Protective effects of fraction 1a of polysaccharides isolated from Solanum nigrum Linne on thymus in tumor-bearing mice. J. Ethnopharmacol. 129:3 (2010), 350–356.
15. [15] Razali, F.N., Ismail, A., Abidin, N.Z., Shuib, A.S., Stimulatory effects of polysaccharide fraction from Solanum nigrum on RAW 264.7 murine macrophage cells. PLoS One, 9(10), 2014, e108988.
16. [16] Mossman, T., Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. J. Immunol. Methods 1–2 (1983), 55–63.
17. [17] Lai, Y.S., Chen, J.Y., Tsai, H.J., Chen, T.Y., Hung, W.C., The SUV39H1 inhibitor chaetocin induces differentiation and shows synergistic cytotoxicity with other epigenetic drugs in acute myeloid leukemia cells. Blood Cancer J., 5(5), 2015, e313.
18. [18] Zhang, D.Y., Wu, J., Ye, F., Xue, L., Jiang, S., Yi, J., Zhang, W., Wei, H., Sung, M., Wang, W., Li, X., Inhibition of cancer cell proliferation and prostaglandin E2 synthesis by Scutellaria baicalensis. Cancer Res. 63:14 (2003), 4037–4043.
19. [19] Chen, J.R., Yang, Z.Q., Hu, T.J., Yan, Z.T., Niu, T.X., Wang, L., Cui, D.A., Wang, M., Immunomodulatory activity in vitro and in vivo of polysaccharide from Potentilla anserine. Fitoterapia 81:8 (2010), 1117–1124.
20. [20] Robertson, D., Savage, K., Reis-Filho, J.S., Isacke, C.M., Multiple immunofluorescence labelling of formalin-fixed paraffin-embedded (FFPE) tissue. BMC Cell Biol., 9(1), 2008, 13.
21. [21] Ramberg, J.E., Immunomodulatory dietry polysaccharides: a systematic review of the literature. Nutr. J., 9, 2010, 54.
22. [22] Im, S.A., Oh, S.T., Song, S., Kim, M.R., Kim, D.S., Woo, S.S., Jo, T.H., Park, Y.I., Lee, C.K., Identification of optimal molecular size of modified Aloe polysaccharides with maximum immunomodulatory activity. Int. Immunopharmacol. 5:2 (2005), 271–279.
23. [23] Zheng, X., Liu, Z., Li, S., Wang, L., Lv, J., Li, J., Ma, X., Fan, L., Qian, F., Identification and characterization of a cytotoxic polysaccharide from the flower of Abelmoschus manihot. Int. J. Biol. Macromol. 82 (2016), 284–290.
24. [24] Zhu, J., Liu, W., Yu, J., Zou, S., Wang, J., Yao, W., Gao, X., Characterization and hypoglycemic effect of a polysaccharide extracted from the fruit of Lycium barbarum L. Carbohydr. Polym. 98:1 (2013), 8–16.
25. [25] Zhao, X., Ma, S., Liu, N., Liu, J., Wang, W., A polysaccharide from Trametes robiniophila inhibits human osteosarcoma xenograft tumor growth in vivo. Carbohydr. Polym. 124 (2015), 157–163.
26. [26] Wu, J., Zheng, J., Xia, X., Kan, J., Purification and structural identification of polysaccharides from bamboo shoots (Dendrocalamus latiflorus). Int. J. Mol. Sci. 16:7 (2015), 15560–15577.
27. [27] Wu, S., Fu, X., Brennan, M.A., Brennan, C.S., Chun, C., The effects of different purifying methods on the chemical properties, in vitro anti-tumor and immunomodulatory activities of Abrus cantoniensis polysaccharide fractions. Int. J. Mol. Sci., 17(4), 2016, 511.
28. [28] Zhao, L., Dong, Y., Chen, G., Hu, Q., Extraction, purification, characterization and antitumor activity of polysaccharides from Ganoderma lucidum. Carbohydr. Polym. 80 (2010), 783–789.
29. [29] Yi, Y., Liao, S.T., Zhang, M.W., Shi, J., Zhang, R.F., Deng, Y.Y., Wei, Z.C., Physicochemical characteristics and immunomodulatory activities of three polysaccharide-protein complexes of longan pulp. Molecules 16:7 (2011), 6148–6164.
30. [30] Popov, S.V., Ovodov, Y.S., Polypotency of the immunomodulatory effect of pectins. Biochemistry (Moscow) 78:7 (2013), 823–835.
31. [31] Plato, A., Willment, J.A., Brown, G.D., C-type lectin-like receptors of the dectin-1 cluster: ligands and signaling pathways. Int. Rev. Immunol. 32:2 (2013), 134–156.
32. [32] Takeuchi, O., Akira, S., Pattern recognition receptors and inflammation. Cell 140:6 (2010), 805–820.
33. [33] Lee, C.C., Houghton, P., Cytotoxicity of plants from Malaysia and Thailand used traditionally to treat cancer. J. Ethnopharmacol. 100:3 (2005), 237–243.
34. [34] Chen, Y., Huang, Y., Cui, Z., Lui, J., Purification, characterization and biological activity of a novel polysaccharide from Inonotus obliquus. Int. J. Biol. Macromol. 79 (2015), 587–594.
35. [35] Wang, Y., Huang, M., Sun, R., Pan, L., Extraction, characterization of a Ginseng fruits polysaccharide and its immune modulating activities in rats with Lewis lung carcinoma. Carbohydr. Polym. 127 (2015), 215–221.
36. [36] Zhao, T., Mao, G., Mao, R., Zou, Y., Zheng, D., Feng, W., Wang, W., Zheng, W., Song, J., Chen, Y., Yang, L., Wu, X., Antitumor and immunomodulatory activity of a water-soluble low molecular weight polysaccharide from Schisandra chinensis (Turcz.) Baill. Food Chem. Toxicol. 55 (2013), 609–616.
37. [37] Li, J., Li, Q.W., Gao, D.W., Han, Z.S., Lu, W.Z., Antitumor and immunomodulating effects of polysaccharides isolated from Solanum nigrum Linne. Phytother. Res. 23:11 (2009), 1524–1530.
38. [38] Liu, J., Zhang, L., Ren, Y., Gao, Y., Kang, L., Qiao, Q., Anti-cancer and immunoregulatory activity of Gynostemma pentaphyllum polysaccharides in H22 tumor-bearing mice. Int. J. Biol. Macromol. 69 (2014), 1–4.
39. [39] Zheng, Y., Wang, W.D., Li, Y., Antitumor and immunomodulatory activity of polysaccharide isolated from Trametes orientalis. Carbohydr. Polym. 131 (2015), 248–254.
40. [40] Fang, J.J., Zhu, Z.Y., Dong, H., Zheng, G.Q., Teng, A.G., Liu, A.J., Effect of spleen lymphocytes on the splenomegaly in hepatocellular carcinoma-bearing mice. Biomed. Environ. Sci. 27:1 (2014), 17–26.
41. [41] Sharp, J.G., Riches, A.C., Littlewood, V., Thomas, D.B., The incidence, pathology and transplantation of hepatomas in CBA mice. J. Pathol. 119:4 (1976), 211–220.
42. [42] Toge, T., Kuroi, K., Kuninobu, H., Yamaguchi, Y., Kegoya, Y., Baba, N., Hattori, T., Role of the spleen in immunosuppression of gastric cancer: predominance of suppressor precursor and suppressor inducer T-cells in the recirculating spleen cells. Clin. Exp. Immunol., 74(3), 1998, 409.
43. [43] Baugh, J.A., Bucala, R., Mechanisms for modulating TNF alpha in immune and inflammatory disease. Curr. Opin. Drug Discov. Dev. 4:5 (2001), 635–650.
44. [44] Wajant, H., The role of TNF in cancer. Death Receptors and Cognate Ligands in Cancer, 2009, Springer, Berlin, Heidelberg, 1–15.
45. [45] Sistigu, A., Viaud, S., Chaput, N., Bracci, L., Proietti, E., Zitvogel, L., Immunomodulatory effects of cyclophosphamide and implementations for vaccine design. Semin. Immunopathol. 33:4 (2011), 369–383.
46. [46] Mosser, D.M., Edwards, J.P., Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8:12 (2008), 958–969.
47. [47] Critchley-Thorne, R.J., Simons, D.L., Yan, N., Miyahira, A.K., Dirbas, F.M., Johnson, D.L., Swettre, S.M., Carlson, R.W., Fisher, G.A., Koong, A., Holmes, S., Lee, P.P., Impaired interferon signaling is a common immune defect in human cancer. Proc. Natl. Acad. Sci. U. S. A. 106:22 (2009), 9010–9015.
48. [48] Bream, J.H., Curiel, R.E., Yu, C.R., Egwuagu, C.E., Grusby, M.J., Aune, T.M., Young, H.A., IL-4 synergistically enhances both IL-2- and IL-12-induced IFN-γ expression in murine NK cells. Blood 102:1 (2003), 207–214.
49. [49] Zhang, G.J., Adachi, I., Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma. Anticancer Res. 19:2B (1999), 1427–1432.
50. [50] Luo, F.K.W., Ko, C.H., Yue, G.G.L., Lee, J.K.M., Li, K.K., Lee, M., Li, G., Fung, K.P., Leung, P.C., Lau, C.B.S., Green tea (Camellia sinensis) extract inhibits both the metastasis and osteolytic components of mammary cancer 4T1 lesions in mice. J. Nutr. Biochem. 25:4 (2014), 395–403.
51. [51] Giannakakis, A., Karapetsas, A., Dangaj, D., Lanitis, E., Tanyi, J., Coukos, G., Sandaltzopoulos, R., Overexpression of SMARCE1 is associated with CD8+ T-cell infiltration in early stage ovarian cancer. Int. J. Biochem. Cell Biol. 53 (2014), 389–398.
52. [52] Wu, J., Lanier, L.L., Natural killer cells and cancer. Adv. Cancer Res. 90 (2003), 127–156.
53. [53] Tannock, I., Hill, R., Bristow, R., Harrington, L., The Basic Science of Oncology. fifth edition, 2013, McGraw-Hill, New York.
54. [54] Klimp, A.H., De Vries, E.G.E., Scherphof, G.L., Daemen, T., A potential role of macrophage activation in the treatment of cancer. Crit. Rev. Oncol. Hematol. 44:2 (2002), 143–161.
55. [55] Waldhauer, I., Steinle, A., NK cells and cancer immunosurveillance. Oncogene 27:45 (2008), 5932–5943.
56. [56] Albertsson, P.A., Basse, P.H., Hokland, M., Goldfarb, R.H., Nagelkerke, J.F., Nannmark, U., Kuppen, P.J., NK cells and the tumour microenvironment: implications for NK-cell function and anti-tumour activity. Trends Immunol. 24:11 (2003), 603–609.
57. [57] Hao, N.B., Lu, M.H., Fan, Y.H., Cao, Y.L., Zhang, Z.R., Yang, S.M., Macrophages in tumor microenvironments and the progression of tumors. Clin. Dev. Immunol., 2012, 2012.
58. [58] Cohen, G.M., Sun, X.M., Snowden, R.T., Dinsdale, D., Skilleter, D.N., Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation. Biochem. J. 286 (1992), 331–334.
59. [59] Gorczyca, W., Gong, J., Darzynkiewicz, Z., Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res. 53:8 (1993), 1945–1951.